News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
59,636 Results
Type
Article (1839)
Company Profile (3)
Press Release (57794)
Section
Business (15085)
Career Advice (20)
Deals (2856)
Drug Delivery (1)
Drug Development (4551)
Employer Resources (2)
FDA (2931)
Job Trends (1004)
News (26106)
Policy (2270)
Tag
2024 BioMidwest Digital (2)
Academia (235)
Adcomms (1)
Allergies (1)
Alliances (2985)
ALS (1)
Alzheimer's disease (5)
Approvals (2940)
Artificial intelligence (9)
Bankruptcy (23)
Best Places to Work (877)
Biosimilars (5)
Biotechnology (1)
Bladder cancer (9)
Brain cancer (9)
Breast cancer (17)
Cancer (158)
Cardiovascular disease (9)
Career advice (20)
CAR-T (2)
Cell therapy (11)
Cervical cancer (2)
Clinical research (4006)
Collaboration (41)
Compensation (9)
COVID-19 (40)
C-suite (9)
Cystic fibrosis (1)
Data (142)
Depression (1)
Diabetes (12)
Diagnostics (329)
Digital health (3)
Drug discovery (3)
Earnings (7193)
Employer branding (1)
Employer resources (2)
Events (7420)
Executive appointments (39)
FDA (3086)
Funding (44)
Gene therapy (14)
GLP-1 (17)
Government (203)
Guidances (5)
Healthcare (2494)
Immunology and inflammation (2)
Indications (2)
Infectious disease (41)
Inflammatory bowel disease (6)
Intellectual property (2)
Interviews (1)
IPO (1129)
Job creations (146)
Job search strategy (20)
Kidney cancer (1)
Layoffs (14)
Legal (426)
Liver cancer (16)
Lung cancer (18)
Management (1)
Manufacturing (5)
Medical device (4262)
Medtech (4263)
Mergers & acquisitions (1754)
Metabolic disorders (18)
Neurodegenerative disease (2)
Neuropsychiatric disorders (1)
Neuroscience (27)
NextGen: Class of 2025 (660)
Non-profit (272)
Northern California (124)
Now hiring (1)
Obesity (6)
Ovarian cancer (9)
Pain (26)
Pancreatic cancer (13)
Parkinson's disease (10)
Patents (14)
Patient recruitment (7)
People (4029)
Phase I (1025)
Phase II (1757)
Phase III (1517)
Pipeline (52)
Postmarket research (169)
Preclinical (337)
Prostate cancer (11)
Radiopharmaceuticals (15)
Rare diseases (11)
Real estate (332)
Regulatory (1798)
Reports (4)
Research institute (150)
Schizophrenia (2)
Series A (4)
Series B (5)
Service/supplier (1)
Sickle cell disease (1)
Southern California (119)
Startups (226)
Supply chain (2)
United States (1586)
Vaccines (11)
Venture capitalists (2)
Weight loss (3)
Women's health (6)
Date
Today (5)
Last 7 days (37)
Last 30 days (180)
Last 365 days (2493)
2025 (602)
2024 (2680)
2023 (3383)
2022 (6285)
2021 (5523)
2020 (4830)
2019 (4097)
2018 (3101)
2017 (3071)
2016 (2850)
2015 (3344)
2014 (2513)
2013 (2221)
2012 (2344)
2011 (2303)
2010 (2018)
Location
Africa (23)
Alabama (2)
Alaska (2)
Arizona (15)
Asia (2766)
Australia (393)
California (308)
Canada (81)
China (22)
Colorado (23)
Connecticut (12)
Delaware (4)
Europe (5432)
Florida (103)
Georgia (65)
Idaho (8)
Illinois (61)
Indiana (30)
Japan (8)
Kansas (7)
Maryland (42)
Massachusetts (200)
Michigan (37)
Minnesota (61)
Missouri (17)
Montana (11)
Nebraska (6)
Nevada (4)
New Hampshire (8)
New Jersey (108)
New Mexico (2)
New York (103)
North Carolina (92)
Northern California (124)
Ohio (22)
Oklahoma (2)
Oregon (5)
Pennsylvania (96)
Rhode Island (4)
South America (43)
South Carolina (2)
Southern California (119)
Tennessee (31)
Texas (79)
Utah (14)
Virginia (9)
Washington State (8)
West Virginia (1)
Wisconsin (4)
59,636 Results for "rti surgical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine
December 17, 2024
·
2 min read
Press Releases
RTI Surgical Completes Acquisition of Collagen Solutions
November 4, 2024
·
1 min read
Press Releases
RTI Surgical celebrates expansion of Tutoplast® Tissue Sterilization Process facility
October 31, 2024
·
2 min read
Deals
RTI Surgical Completes Acquisition of Cook Biotech
RTI Surgical, an industry leading contract development and manufacturing organization, serving the regenerative medicine industry, announced that it has completed its previously announced acquisition of Cook Biotech Incorporated.
February 1, 2024
·
3 min read
Press Releases
RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction
November 25, 2024
·
2 min read
Deals
RTI Surgical Announces Agreement to Acquire Cook Biotech from Cook Group
RTI Surgical announced that it has signed a definitive agreement to acquire Cook Biotech Incorporated, a leader in advanced tissue-repair products from biomaterials, headquartered in West Lafayette, Indiana.
January 8, 2024
·
4 min read
Press Releases
RTI Surgical appoints Chad Croasdale as Chief Commercial Officer
July 11, 2024
·
2 min read
Press Releases
RTI Announces its Second Annual Medical Technology Forum Featuring Speakers from NVIDIA, Medtronic, and Asensus Surgical
October 2, 2024
·
2 min read
Deals
Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical
Xtant Medical Holdings, Inc. announced that it has acquired the nanOss production operations from RTI Surgical, Inc., a leading CDMO in regenerative medicine.
October 23, 2023
·
5 min read
FDA
RTI Surgical Inc. Receives FDA IDE Approval for the Clinical Investigation of Cortiva® Allograft Dermis in Breast Reconstruction
RTI Surgical, a leading global medical device organization, announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for a clinical study designed to confirm the safety and effectiveness of Cortiva ® Allograft Dermis in implant-based breast reconstruction.
November 27, 2023
·
2 min read
1 of 5,964
Next
